ProfileGDS5822 / ILMN_2543061
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 34% 4% 22% 17% 25% 14% 8% 16% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 116.634
GSM1276600PDAC Late Ablation Control 29.24
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 111.722
GSM1276603PDAC Late Ablation 211.117
GSM1276604PDAC Late Ablation 313.625
GSM1303940PDAC Late Ablation_anti-CTLA4 11114
GSM1303941PDAC Late Ablation_anti-CTLA4 25.78
GSM1303942PDAC Late Ablation_anti-CTLA4 39.216